What buyers look for in a behavioral health practice

A buyer is not assessing whether your practice is good. They are assessing what survives you leaving, and those are very different questions.

This is the gap that makes diligence feel personal. You are being asked about the thing you built, by someone who appears indifferent to most of what you are proudest of. They are not indifferent — they are pricing a specific risk, and your clinical excellence is only relevant to them insofar as it stays after you go.

The question underneath every question

Every item below is a specific form of one question: does this run without the owner?

Once you see it, diligence stops feeling arbitrary. The buyer is building a picture of the practice on the day after you hand over the keys, and every request is aimed at some part of that picture they cannot yet see.

Owner dependency

The heaviest single factor, and the one owners most consistently underrate.

The number a buyer wants is what share of revenue you personally generate. Under about ten percent, you are effectively already out of the clinical seat and the practice is demonstrably a business rather than a job. Over half, you are the practice, and what is being sold is a caseload that may not transfer to anyone.

Two consequences, and both hurt. Your production is subtracted from earnings at replacement cost before the multiple is applied — the arithmetic is in SDE vs EBITDA. And separately, heavy owner dependency pulls the multiple itself down, because the earnings that remain are less certain to persist.

Whether the revenue transfers

The question here is not how much revenue you have. It is how much of it a buyer still has ninety days after closing.

Payer contracts are the crux. Held by the entity under a group NPI, they can transfer with the entity. Following individual clinicians, they do not — and the buyer faces re-credentialing every clinician, which takes months. During those months the work happens and the payment does not.

Buyers price that gap, and they price it conservatively, because they have seen it run longer than anyone promised. Expect it to show up as a lower number, a larger holdback, or an earnout that only pays if the revenue actually arrives.

Cash-pay revenue scores lower than owners expect, and this is worth defending because it feels wrong. A cash-pay practice often has better margins, no payer headaches, and a happier clinical experience. But cash-pay clients frequently follow the clinician rather than the practice, there is no contract binding the revenue to the entity, and there is nothing for a buyer to acquire except a client list and goodwill. Contracted revenue is duller and more transferable, and buyers pay for transferable.

The team

A buyer assumes some attrition after closing. What they are working out is how much.

Tenure is the main signal. Eight clinicians averaging five years is a different asset from eight averaging fourteen months, even at identical revenue.

Concentration is the next. If one clinician generates a third of revenue, that is not a team — that is a second key-person risk sitting behind the first.

Agreements are binary. Signed, current, with restrictive covenants where your state allows them, or not. Informal arrangements with people who have worked for you for years feel like trust; to a buyer they read as a team with nothing holding it.

A clinical director who is not you is worth more than most owners realise. It is the clearest evidence that clinical operations continue without the owner, and it changes which buyers will look at you at all.

Licensure and authorisations

Frequently the most valuable thing you own, and it rarely appears on a balance sheet.

A state certificate of approval, CCBHC status, CMHC designation, an opioid treatment programme licence, CARF or Joint Commission accreditation — anything that takes a buyer months or years to obtain themselves is worth real money, because acquiring you is faster than applying.

It also constrains the deal structure, sometimes decisively. Authorisations are generally issued to an entity and do not travel with assets, which can force a sale of the entity rather than its assets. That has consequences for your tax position and your post-closing risk — see asset sale vs stock sale.

Systems, or whether it is all in your head

The question a buyer is really asking is whether they could operate this practice on the Monday after you stop answering the phone.

There is a ladder here, and most owners are further down it than they think:

Nothing written down. Scheduling rules, intake decisions, billing follow-up, who gets which referral — all of it lives in your judgement. This is common and it is heavily penalised, because what is being sold cannot be handed over.

Partially documented. An EHR configured properly, some written process, a lot still improvised. Most practices are here.

Documented processes. Someone new could read how the practice runs. Intake, billing, onboarding, supervision cadence, escalation.

Demonstrably operable without you. Not just written down but already happening — you took three weeks off and nothing degraded.

The last rung is the one that changes the buyer pool rather than just the price. It is also, unlike almost everything else on this page, something you can move in twelve months without spending much money.

The lease and the premises

Rarely decisive, occasionally fatal.

A long assignable lease at market rent is invisible — which is what you want. Month-to-month means the buyer inherits a landlord negotiation on top of everything else. A lease with a change-of-control clause hands the landlord leverage at exactly the moment you have none.

If you own the building personally and rent it to the practice, expect the rent to be normalised to market in the earnings calculation, and expect a conversation about whether the buyer is also buying the building or signing a lease with you. That second conversation is worth planning for, because “my former landlord is also my seller” is a complication some buyers decline.

Fully remote practices score well on premises risk and less well elsewhere — there is no lease to worry about, but also less holding the clinicians in place.

Demand, and whether it survives you

A waitlist is evidence that revenue is limited by capacity rather than by demand, which is the single most attractive position to sell from. A buyer can see how to grow it: hire.

Declining referrals are the opposite, and no amount of documentation compensates. But the question a buyer asks is sharper than volume — where does the demand come from? A waitlist fed by payer directories, a website that ranks, and institutional referral relationships belongs to the practice. A waitlist fed by your name, your reputation, and colleagues who refer to you walks out with you. The first is an asset. The second is owner dependency described in flattering terms.

Documentation and diligence risk

Not clinical quality. Audit survivability.

If a payer could review a sample of your notes and recoup payments, that exposure transfers to the buyer, and diligence exists partly to find it. A sample will be pulled and read.

This is where deals die, and where they die late — after months, after legal fees, after you have told your leadership team. Weak documentation is one of the few findings that can turn a signed letter of intent into a withdrawn one rather than a renegotiated one.

What buyers do not care about as much as you do

The uncomfortable part, and the reason this page is worth your time.

Your clinical reputation matters to a buyer only to the extent it is attached to the practice rather than to you. If referrals come because of your name, that is owner dependency wearing a nicer coat.

Awards, credentials and speaking. Yours, not the practice’s, and they leave with you.

The website and the brand. A buyer with a platform is replacing both.

Your specific modality. The thing that most distinguishes your practice clinically is very often not priced at all. Buyers are underwriting whether insured lives keep getting seen and claims keep getting paid.

None of this means the work did not matter. It means the sale is valuing a different thing than the career, and sellers who expect the price to reflect the career find the process much harder than sellers who do not.

---

The calculator scores your practice on all of the above and tells you which three things are adding the most to your value and which three are costing you the most. Free, about four minutes.